IRCT20210306050600N1招募中2 期
Evaluation of addition of concurrent Capecitabine to brachytherapy in patients with advanced cervical cancer
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- Female
入选标准
- •definite diagnosis of cervical cancer in the pathological sample
- •histology of SCC or Adenocarcinoma
- •stage IB-IVA based on gynecologic examination and imaging, making these patients chemoradiotherapy candidates
- •no evidence of distant metastasis
- •adequate performance status ( ECOG =2)
排除标准
- •not willing to enter the trial
- •uncontrolled comorbidities, like diabetes mellitus and hypertension
- •warfarin use
研究者
相似试验
进行中（未招募）
不适用
A phase II study of Capecitabine in combination with Cisplatin in advanced head and neck Cancer - NDAdvanced or metastatic head and neck cancerLevel: HLTClassification code 10024530EUCTR2006-003775-13-ITOSPEDALE ONCOLOGICO DI BARI43
进行中（未招募）
不适用
A phase II study of Capecitabine in combination with oral vinorelbine in advanced Breast Cancer - NDEUCTR2006-003752-38-ITOSPEDALE ONCOLOGICO DI BARI
已完成
不适用
Phase I/II Study of Capecitabine in Combination with Peginterferon Alfa-2a for Patients with Advanced Hepatocellular CarcinomaHepatocellular CarcinomaJPRN-UMIN000005697Chiba University Hospital42
进行中（未招募）
1 期
STUDY OF CAPECITABINE PLUS CONCOMITANT RADIATION THERAPY FOLLOWED BY DURVALUMAB AS PREOPERATIVE TREATMENT IN PATIENTS WITH RECTAL CANCERocally advanced (T3-4 N0-1) rectal cancer.MedDRA version: 21.0Level: PTClassification code 10038019Term: Rectal adenocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-004758-39-ITAZIENDA UNITÀ SANITARIA LOCALE DELLA ROMAGNA60
已完成
1 期
Phase I study of a combination of capecitabine plus CPT-11 (CC therapy) in patients with metastatic colon cancer refractory to oxaliplatin containing chemotherapyColorectal cancerJPRN-UMIN000003176Osaka Medical Center for Cancer and Cardiovascular Diseases24